source
- Roche signs discovery partnerships with Atavistik Bio and Earendil LabsRoche announced new collaborations with the drug discovery companies Atavistik Bio and Earendil Labs to develop early-stage candidates. The agreements continue a recent wave of dealmaking by the S…
- Acadia’s Alzheimer’s psychosis drug misses Phase 2 goals, but moves to revised Phase 3Acadia Pharmaceuticals announced that its experimental treatment for psychosis linked to Alzheimer’s disease failed to meet the primary endpoints in a Phase 2 trial. The company said the data stil…